Empagliflozin Use among Patients with Heart Failure in the Outpatient Department of Medicine in a Tertiary Care Centre
Introduction: Sodium-glucose co-transporter 2 inhibitors were initially used in the treatment of type 2 diabetes mellitus and subsequently, it was shown to be useful in heart failure among patients with or without diabetes mellitus. This study aimed to find out the prevalence of empagliflozin use a...
Main Authors: | Rinku Ghimire, Sinet Pokharel, Raju Jayshwal, Rupesh Kumar Shreewastav |
---|---|
Format: | Article |
Language: | English |
Published: |
Nepal Medical Association
2023-10-01
|
Series: | Journal of Nepal Medical Association |
Subjects: | |
Online Access: | https://jnma.com.np/jnma/index.php/jnma/article/view/8288 |
Similar Items
-
Empagliflozin and the Prevention of Heart Failure
by: Douglas L. Mann, MD, et al.
Published: (2017-08-01) -
Evaluation of Prescription Pattern of Analgesics at Emergency Department of Tertiary Care Hospital: A Descriptive Cross-Sectional Study
by: Rinku Ghimire, et al.
Published: (2023-07-01) -
Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure
by: Michael Gotzmann, et al.
Published: (2023-07-01) -
Preventing Dementia—A Cross-Sectional Study of Outpatients in a Tertiary Internal Medicine Department
by: Ioana-Alexandra Sandu, et al.
Published: (2023-11-01) -
PRESCRIPTION AUDIT IN OUTPATIENT DEPARTMENTS OF TERTIARY CARE HOSPITALS; FACTS AND RECOMMENDATIONS
by: Muhammad Wasiullah Khan, et al.
Published: (2021-04-01)